News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Digital Currency X Technology priced a registered direct offering to raise about $5.0 million.
  • The offering sells ordinary shares and accompanying warrants.
  • Digital Currency X Technology trades on Nasdaq.
  • Net proceeds will fund working capital and general corporate purposes.
  • Proceeds will support digital asset management and ecosystem initiatives.
  • Warrant issuance creates future dilution risk if warrants are exercised.

Latest Articles

Xerox Shares Jump After Q2 Profit Surprise and Outlook Raise

Xerox Shares Jump After Q2 Profit Surprise and Outlook Raise

Xerox shares leapt 22.4% in pre-open trading after the company reported a return to profitability in the second quarter of 2026, posted double-digit year-over-year revenue growth, and raised its fiscal 2026 outlook. The quarter included a $105 million pre-tax benefit tied to IEEPA tariff receivables and showed an adjusted profit versus an adjusted …

Bank of England Divided Over Next Move as Rates Held at 3.75%

Bank of England Divided Over Next Move as Rates Held at 3.75%

The Bank of England's Monetary Policy Committee voted 6-3 to keep Bank Rate at 3.75%, with a majority opting to wait for clearer evidence on energy-driven inflation and second-round effects. Three members advocated an immediate increase to 4% to address upside risks tied to geopolitical tensions and commodity volatility.

Amneal Shares Jump After Broad Q2 Beat and Second Guidance Raise

Amneal Shares Jump After Broad Q2 Beat and Second Guidance Raise

Amneal Pharmaceuticals jumped roughly 10% in pre-market trading after reporting a stronger-than-expected second quarter. The Bridgewater, New Jersey-based company beat revenue and adjusted EPS forecasts, raised its full-year guidance for the second time in 2026, and highlighted a pending biosimilars-related transaction as a strategic growth avenue.…

Bank of England Holds Rates at 3.75% as Split on Further Tightening Widens

Bank of England Holds Rates at 3.75% as Split on Further Tightening Widens

The Bank of England's Monetary Policy Committee voted 6-3 to maintain Bank Rate at 3.75%, with three members preferring a rise to 4% as renewed conflict between the United States and Iran lifted risks to energy markets. Governor Andrew Bailey and the majority of the MPC continued a wait-and-see strategy aimed at preventing inflation from drifting s…

Rocket Lab Wins Three-Launch Contract with iQPS; Shares Tick Higher

Rocket Lab Wins Three-Launch Contract with iQPS; Shares Tick Higher

Rocket Lab's stock rose after the company announced a new multi-launch agreement with Institute for Q-shu Pioneers of Space (iQPS) covering three dedicated Electron missions. The contract increases iQPS's booked launches with Rocket Lab to 18 and includes the purchase of Rocket Lab's Motorized Lightband separation system. The missions, each carryin…

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

EyePoint, Inc. has successfully completed enrollment of over 480 patients in its global Phase 3 COMO and CAPRI trials evaluating DURAVYU™ (vorolanib intravitreal insert) for diabetic macular edema (DME). Enrollment finished ahead of schedule within five months, reflecting strong interest among the retinal specialist community. DURAVYU is a sustaine…

HII Reports Second Quarter 2026 Results

HII Reports Second Quarter 2026 Results

Huntington Ingalls Industries (NYSE: HII) reported robust second quarter 2026 results with revenues rising 10.9% year-over-year to $3.4 billion and net earnings increasing by 36.8% to $208 million ($5.27 diluted EPS). The company raised its full-year 2026 shipbuilding revenue guidance to $10.2-$10.4 billion and improved the lower end of the shipbui…

LKQ Corporation Announces Results for Second Quarter 2026

LKQ Corporation Announces Results for Second Quarter 2026

LKQ Corporation reported second quarter 2026 results showing a 3% revenue decline to $3.4 billion, with net income and adjusted net income decreasing compared to prior year. North America segment achieved positive organic growth driven by increased alternative parts usage, while Europe underperformed due to ERP implementation issues. The company co…

AMC Global Media Inc. Reports Second Quarter 2026 Results

AMC Global Media Inc. Reports Second Quarter 2026 Results

AMC Global Media Inc. reported its Q2 2026 financial results, emphasizing a new global co-exclusive content licensing agreement with Netflix for the streaming rights to the entire Walking Dead Universe, generating $500 million over five years. While the company renewed key distribution agreements and increased full-year guidance, Q2 revenues declin…

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Mangoceuticals, Inc. has entered into a business combination agreement with Nuclea Energy Inc., a Canadian advanced nuclear technology firm developing the Morpheus lead-cooled microreactor. The transaction will bring Nuclea public via Mangoceuticals’ Nasdaq listing, supporting Nuclea's advancement toward commercialization amid growing electricity d…

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air, a NASDAQ-listed commercial-stage medical device and biopharmaceutical company, announced a private placement offering of up to $30.1 million at-the-market under Nasdaq rules. The financing involves the sale of common stock, pre-funded warrants, and accompanying Series A and B warrants to institutional healthcare investors and company in…